Two batches of IPS melatonin 10mg capsules recalled

Two batches of IPS melatonin 10mg capsules recalled

July 19 2018 IPS Specials is recalling two batches of its melatonin 10mg capsules, due to an...

Government considering how to implement changes to specials reimbursement

Government considering how to implement changes to specials reimbursement

May 25 2018 The government is still considering how to implement legislation passed last year...

Price of specials medicines to come under further scrutiny

Price of specials medicines to come under further scrutiny

May 9 2018 The Government says that new regulations will strengthen controls around pricing for...

Specials Drug Tariff updated for February

Specials Drug Tariff updated for February

February 2 2018 The Drug Tariffs relating to specials medicines has been updated for the February...

Special Products becomes Veriton Pharma

Special Products becomes Veriton Pharma

October 3 2017 Special Products Ltd has changed its name to Veriton Pharma Limited, to better...

  • Two batches of IPS melatonin 10mg capsules recalled

    Two batches of IPS melatonin 10mg capsules recalled

    Thursday, 19 July 2018 10:25
  • Government considering how to implement changes to specials reimbursement

    Government considering how to implement changes to specials reimbursement

    Tuesday, 29 May 2018 12:30
  • Price of specials medicines to come under further scrutiny

    Price of specials medicines to come under further scrutiny

    Wednesday, 09 May 2018 15:21
  • Specials Drug Tariff updated for February

    Specials Drug Tariff updated for February

    Friday, 02 February 2018 14:10
  • Special Products becomes Veriton Pharma

    Special Products becomes Veriton Pharma

    Tuesday, 03 October 2017 18:03

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

QPL logo with group strapline high res 300dpi.jpegAugust 18 2017

Quantum Pharmaceutical is updating its ordering system for Specials medicines to allow ordering directly from its website. The new online system will come into effect from September 1, and will email customers with an order confirmation.

 The move follows the updating of its documentation to reflect a recent statement from the medicines regulator. The MHRA stated that, to protect patient safety, all orders for unlicensed products from Specials medicines manufacturers need to be in writing, “for example by email, fax or via an on line ordering system provided by the manufacturer.”

Quantum Pharmaceutical said: “As quality underpins everything we do at Quantum Pharmaceutical we have added additional ordering documentation to our website, which clearly defines the four different ordering channels available (phone, fax, email and online) and the steps to take for each to ensure full compliance.”

In cases where a customer has phoned the company to order a product, Quantum will issue an order statement by fax or email, which the customer is then required to sign and return to Quantum for the order to be processed.

Quantum has also flagged up updates to the latest versions of the Specials Drug Tariffs for England and Wales and for Scotland which came into effect from August 1.

Drug Tariff Part VIIIB changes for England and Wales include five deletions, three additions, meaning that 252 items are included in the Tariff. There were no changes to Part 7S in the Scottish Tariff, meaning 71 items are listed.

Quantum Pharmaceutical said: “We have incorporated price and line updates into our processes to ensure all customer paperwork and endorsing information are accurate. All orders placed with Quantum Pharmaceutical from August 1 2017 will include the relevant changes.”

The next tariff update is due on November 1.

Link:
Quantum Pharmaceutical Announcement            
QP Summary of ordering process               
Specials Drug Tariff announcement          

Specials News

July 20 2018 A consultation asking for views on how the safety features required under the Falsified Medicines Directive should be implemented has been issued.
July 20 2018 A consultation asking for views on how the safety features required under the Falsified Medicines Directive should be implemented has been issued. The MHRA has launched the consultation with...